| Identification | More | [Name]
ANTIMONY SODIUM TARTRATE | [CAS]
34521-09-0 | [Synonyms]
ANTIMONY SODIUM TARTRATE
SODIUM ANTIMONYL-L-TARTRATE
SODIUM ANTIMONY TARTRATE
antimonylsodiumtartrate
antimonysodiumoxidel-(+)-tartrate
bis(mu-(2,3-dihydroxybutanedioato(4-)-o1,o2:o3,o4))di-antimonate(2-disod
diantimonyditartratedisodium
emetosodium
ium,stereoisomer
natriumantimonyltartrat
sodiumantimonyltartrate
stibnal
stibunal
Sodium antimonyl-L-tartrate, 98+%
Antimonate(2-), bis[μ-[(2R,3R)-2,3-di(hydroxy-kO)butanedioato(4-)-kO1:kO4]]di-, disodium
Antimonate(2-), bis[μ-[2,3-dihydroxybutanedioato(4-)-O1,O2:O3,O4]]di-, disodium, stereoisomer
Antimony sodium oxide tartrate (7CI)
Butanedioic acid, 2,3-dihydroxy-[R-(R*,R*)]-, antimony complex
Diantimony ditartrate disodium (6CI)
Disodium bis(R,R-tartrato)diantimonate(2-) | [EINECS(EC#)]
252-070-9 | [Molecular Formula]
C4H4NaO7Sb | [MDL Number]
MFCD00065402 | [Molecular Weight]
308.82 | [MOL File]
34521-09-0.mol |
| Safety Data | Back Directory | [Risk Statements ]
R20/22:Harmful by inhalation and if swallowed .
R51/53:Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment . | [Safety Statements ]
S61:Avoid release to the environment. Refer to special instructions safety data sheet . | [RIDADR ]
1549 | [RTECS ]
CC8050000 | [HazardClass ]
6.1 | [PackingGroup ]
III | [Safety Profile]
Poison by
subcutaneous, intravenous, and
intraperitoneal routes. Human toxic effects
by intravenous route. Human mutation data
reported. See also ANTIMONY
COMPOUNDS. When heated to
decomposition it emits toxic fumes of Sb. | [Toxicity]
LD i.v. in mice: 25 mg/kg (Fargher, Gray) |
|
| Company Name: |
|
| Tel: |
821-50328103-801 18930552037 |
| Website: |
http://m.is0513.com/ShowSupplierProductsList13285/0.htm |
| Company Name: |
Alfa Aesar
|
| Tel: |
400-6106006 |
| Website: |
http://chemicals.thermofisher.cn |
|